hepatocellular carcinoma造句31) Objective To investigate the change of liver fibrotic indicator in the hepatocellular carcinoma(HCC)patients after repeated transcatheter arterial infusion chemotherapy and embolization(TAE).
32) Objective To investigate the clinical and imaging characteristics of acute hemoperitoneum due to spontaneous rupture of hepatocellular carcinoma (HCC).
33) Objective:To study the perioperative changes of blood lipids in hepatocellular carcinoma(HCC) patients undergoing hepatectomy and their relationship with prealbumin and aminopherase.
34) Methods:The hepatic dual phase helical CT scanning of 7 cases of pedunculated hepatocellular carcinoma were reviewed retrospectively.
35) Objective To explore the correlation between chromosome fragile site in peripheral blood lymphocytes and proto-oncogene expression rate in patients with hepatocellular carcinoma.
36) Differentiation between the echinococcal cyst and hepatocellular carcinoma on CT images evoked diagnostic difficulty before operation.
37) Objective : To study sodium cantharidate induced apoptosis of human hepatocellular carcinoma cells in vitro.
38) Liver resection should still be considered the first-line treatment for patients with hepatocellular carcinoma(HCC) in non-cirrhotic and resectable livers.
39) The satellite nodules of this hepatocellular carcinoma represent either intrahepatic spread of the tumor or multicentric origin of the tumor.
40) Objective: To investigate DSA findings and clinical value of interventional treatment on hemoperitoneum due to spontaneous rupture of hepatocellular carcinoma.
41) Objective: To determine sialidase activity in human hepatocellular carcinoma(HCC) so as to probe into the mechanism of gangliosides change(GD3 increasing)in HCC.
42) Single cell suspension was prepared bom the fresh hepatocellular carcinoma tissue by using mechanical trituration method.
43) Objective To study the mechanism of spontaneous rupture of hepatocellular carcinoma ( HCC ) .
44) Objective To study the antitumor effect of phosphorus-32 glass microspheres ( 32 P GMS) intratumoral injected to the implanted human hepatocellular carcinoma cell mass of nude mice.
45) Objective To explore the curative effect of hepatocellular carcinoma with arteriovenous shunt treated with interventional.
46) Objective : To improve the ultrasonographic diagnostic rate of diffuse hepatocellular carcinoma.
47) Objective To explore the significance of PTEN (phosphatase and tensin homolog deleted on chromosome 10) in the development of human primary hepatocellular carcinoma (HCC).
48) In 2 cases of hepatocellular carcinoma boiloff of the tissue around the antenna was observed by real-time biplane imaging during microwave coagulation.
49) Cryosurgery is an important treatment modality for unresectable hepatocellular carcinoma (HCC).
50) At last , hEra was detected in the hepatocellular carcinoma of 54 cases by immunohistochemistry.
51) Conclusion: Ultrasonography has important value in the diagnosis of hepatocellular carcinoma.
52) Objective:To investigate the color Doppler signals of hepatocellular carcinoma(HCC) after intravenous injection of perfluorocarbon contrast agent.
53) Conclusion Gelatinase A may play an important role in the progression of primary hepatocellular carcinoma.
54) Hepatocellular carcinoma ( HCC ) was positive for PNA, PHA, UEA and SBA.
55) Aim: To detect the methylation at the promoter P3 of human insulin-like growth factor II (IGF-II) gene in hepatocellular carcinoma.
56) Sclerosing (or scirrhous) hepatocellular carcinoma is a subtype of hepatocellular carcinoma.
57) Objective To study the safety and efficacy of transhepatic arterial infusion embolization using microspheres combined with lipiodol for treatment of hepatocellular carcinoma(HCC).
58) Objective To explore the expression of oncostatin M(OSM) and its receptor(OSMR) at the clinical stages of hepatoma tissues and possible mechanisms by which they affect hepatocellular carcinoma (HCC).
59) Regionally, these infections usually accounted for more than 50 % of hepatocellular carcinoma and cirrhosis cases.
60) Patients cycled between the following health states: viral suppression, ongoing viremia, seroconversion, hepatocellular carcinoma, cirrhosis and death.